2021
DOI: 10.21037/atm-20-7974
|View full text |Cite
|
Sign up to set email alerts
|

Effect of activation of the Akt/mTOR signaling pathway by EEF1A2 on the biological behavior of osteosarcoma

Abstract: Background: Osteosarcoma (OS) is a common bone cancer in children and adolescents which causes a large number of cancer-related deaths. Eukaryotic Translation Elongation Factor 1 Alpha 2 (EEF1A2) has been revealed to have carcinogenic properties and promote tumor progression in many cancers. We want to investigate the biological function and mechanism of EEF1A2 in OS.Methods: The expression of EEF1A2 in OS was investigated using the Gene Expression Omnibus (GEO) database and quantitative reverse transcription … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 21 publications
(24 reference statements)
0
9
0
Order By: Relevance
“…1F ). Genes are mainly involved in the pathways including cAMP, ErbB, Rap1, and PI3K-Akt, and EEF1A2 was reported to activate the Akt/mTOR pathway [ 21 ]. Our result showed that EEF1A2 was poorly expressed in SCI (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…1F ). Genes are mainly involved in the pathways including cAMP, ErbB, Rap1, and PI3K-Akt, and EEF1A2 was reported to activate the Akt/mTOR pathway [ 21 ]. Our result showed that EEF1A2 was poorly expressed in SCI (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The SCI rat model was initially established. Next, 20 genes with high correlation scores with SCI were identified, among which EEF1A2 can activate the Akt/mTOR pathway [ 21 ]. Our results showed decreased expressions of EEF1A2, p-Akt/Akt, and p-mTOR/mTOR in SCI rats.…”
Section: Discussionmentioning
confidence: 99%
“…From cancer studies, it was established that eEF1A proteins can promote cell growth and proliferation by serving as an upstream activator of PI3K/AKT/mTOR [ 13 , 42 ] and/or PI3K/AKT/STAT3 [ 14 , 15 ] pathways. In partial agreement with those in vitro studies, our results showed that in an in vivo model of CNS injury, the overexpression of eEF1A proteins elevated mTOR activity, whereas co-overexpressing both proteins had no synergistic effect.…”
Section: Discussionmentioning
confidence: 99%
“…From cancer studies, it was established that eEF1A proteins can promote cell growth and proliferation by serving as an upstream activator of PI3K/AKT/mTOR 12,41 and/or PI3K/AKT/STAT3 13,14 pathways. In partial agreement with those in vitro studies, our results showed that in an in vivo model of CNS injury, the overexpression of eEF1A proteins elevated mTOR activity, whereas co-overexpressing both proteins had no synergistic effect.…”
Section: Discussionmentioning
confidence: 99%